By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BELLUS Health 

275 Armand-Frappier Boulevard

Laval  Quebec  H7V 4A7  Canada
Phone: 450-680-4500 Fax: 450-680-4501


SEARCH JOBS


Industry
Pharmaceutical






Company News
Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) And BELLUS Health Announce Completion Of Enrollment In The Phase III Confirmatory Study of Kiacta™ For The Treatment Of AA Amyloidosis 5/28/2014 9:18:38 AM
Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) And BELLUS Health Announce Engagement Of Financial Advisor To Explore Sale Of KIACTA™, An Experimental Drug In Phase 3 Development For The Treatment Of AA Amyloidosis 5/7/2014 10:36:07 AM
Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) And BELLUS Health Announce Licence Agreement With Mount Sinai For KIACTATM In Sarcoidosis 5/2/2014 11:04:51 AM
BELLUS Health And AmorChem l.p. Announce A Partnership To Develop Drug Candidates For AL Amyloidosis 12/19/2013 1:24:55 PM
BELLUS Health Reports Results for Second Quarter Ended June 30, 2011 8/10/2011 10:41:32 AM
BELLUS Health Exercises Option to Terminate Lease 1/14/2011 12:10:37 PM
BELLUS Health and Celtic Therapeutics Enter Agreement Worth $20 Million for Drug candidate KIACTA(TM) 4/30/2010 1:08:14 PM
Geller Biopharm Successfully Advises BELLUS Health in Its KIACTA(TM) Transaction With Celtic Therapeutics 4/30/2010 10:38:16 AM
Roberto Bellini Appointed President and CEO of BELLUS Health 12/15/2009 6:44:10 AM
BELLUS Health Reports Results for First Half of Fiscal 2009 8/12/2009 8:49:25 AM
12
//-->